0.57Open0.57Pre Close0 Volume1 Open Interest7.00Strike Price0.00Turnover166.87%IV26.85%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.57Extrinsic Value100Contract SizeAmericanOptions Type-0.2215Delta0.0824Gamma15.42Leverage Ratio-0.0242Theta-0.0014Rho-3.42Eff Leverage0.0064Vega
Terns Pharmaceuticals Stock Discussion
Larger Image: tradingview.com...
$Terns Pharmaceuticals(TERN.US)$
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
Terns Pharmaceuticals announced new preclinical data supporting their compound TERN-501 in combination with a GLP-1 receptor agonist for treating obesity. The data was presented at the ADA’s 84th Annual Scientific Sessions. TERN-501, a highly selective THR-...
Larger Image: tradingview.com...
$Terns Pharmaceuticals(TERN.US)$
Larger Image: tradingview.com...
$Terns Pharmaceuticals(TERN.US)$
NEWS
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
Larger Image: tradingview.com...
$Terns Pharmaceuticals(TERN.US)$
Larger Image: tradingview.com...
$Terns Pharmaceuticals(TERN.US)$
No comment yet